Visinin‐like 1 , a novel target gene of the Wnt/β‐catenin signaling pathway, is involved in apoptosis resistance in colorectal cancer
Cancer Medicine · 2023
DOI: 10.1002/cam4.5970 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Hiroki Tage und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Wnt Signaling Pathway, Neurocalcin. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Abnormal activation of Wnt/β‐catenin signaling is associated with various aspects of cancer development. This study explored the roles of novel target genes of the Wnt/β‐catenin signaling pathway in cancer cells.
Methods
Using the haploid chronic myelogenous leukemia cell line HAP1, RNA sequencing (RNA‐seq) was performed to identify genes whose expression was increased by APC disruption and reversed by β‐catenin knockdown (KD). The regulatory mechanism and function of one of the candidate genes was investigated in colorectal cancer (CRC) cells.
Results
In total, 64 candidate genes whose expression was regulated by Wnt/β‐catenin signaling were identified. Of these candidate genes, the expression levels of six were reduced by β‐catenin KD in HCT116 CRC cells in our previous microarray. One of these genes was Visinin‐like 1 ( VSNL1 ), which belongs to the neuronal calcium‐sensor gene family. The expression of VSNL1 was regulated by the β‐catenin/TCF7L2 complex via two TCF7L2‐binding elements in intron 1. VSNL1 KD‐induced apoptosis in VSNL1‐positive CRC cells. Additionally, forced expression of wild‐type VSNL1, but not a myristoylation, Ca 2+ ‐binding, or dimerization‐defective mutant, suppressed the apoptosis induced by camptothecin and doxorubicin in VSNL1‐negative CRC cells.
Conclusion
Our findings suggest that VSNL1 , a novel target gene of the Wnt/β‐catenin signaling pathway, is associated with apoptosis resistance in CRC cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Hiroki Tage, Kiyoshi Yamaguchi, Saya Nakagawa, So Kasuga, Kiyoko Takane, Yoichi Furukawa, Tsuneo Ikenoue
Zitieren
APA
Tage, H., Yamaguchi, K., Nakagawa, S., Kasuga, S., Takane, K., Furukawa, Y., & Ikenoue, T. (2023). Visinin‐like 1 , a novel target gene of the Wnt/β‐catenin signaling pathway, is involved in apoptosis resistance in colorectal cancer. Cancer Medicine. https://doi.org/10.1002/cam4.5970
Vancouver
Tage H, Yamaguchi K, Nakagawa S, Kasuga S, Takane K, Furukawa Y, et al. Visinin‐like 1 , a novel target gene of the Wnt/β‐catenin signaling pathway, is involved in apoptosis resistance in colorectal cancer. Cancer Medicine. 2023. doi:10.1002/cam4.5970
BibTeX
@article{Tage2023,
author = {Tage, Hiroki and Yamaguchi, Kiyoshi and Nakagawa, Saya and Kasuga, So and Takane, Kiyoko and Furukawa, Yoichi and Ikenoue, Tsuneo},
title = {Visinin‐like 1 , a novel target gene of the Wnt/β‐catenin signaling pathway, is involved in apoptosis resistance in colorectal cancer},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.5970}
}
EUVIMED